GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Float Percentage Of Total Shares Outstanding

Kindstar Globalgene Technology (HKSE:09960) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kindstar Globalgene Technology's float shares is 0.00 Mil. Kindstar Globalgene Technology's total shares outstanding is 1,033.66 Mil. Kindstar Globalgene Technology's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kindstar Globalgene Technology's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kindstar Globalgene Technology's Institutional Ownership is 1.19%.


Kindstar Globalgene Technology Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Kindstar Globalgene Technology's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,033.66
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindstar Globalgene Technology Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.
Executives
Orbimed Asia Partners Iv, L.p. 2101 Beneficial owner
Orbimed Asia Gp Iv, L.p. 2201 Interest of corporation controlled by you
Orbimed Advisors Iv Limited 2201 Interest of corporation controlled by you
Cpe Holdings International Limited 2201 Interest of corporation controlled by you
Cpechina Fund Iii, L.p. 2201 Interest of corporation controlled by you
Cpe Holdings Limited 2201 Interest of corporation controlled by you
Cpe Funds Iii Limited 2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited 2101 Beneficial owner
Jackson Hole Trust Company
Huang Bo
Huang Shiang 2101 Beneficial owner
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Huang Zuie-chin 2101 Beneficial owner
Tu Zanbing
Kastle Limited 2301 Trustee

Kindstar Globalgene Technology Headlines

No Headlines